| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 8 | |
| #2 | EPO (European Patent Office) | 6 | |
| #3 | Canada | 5 | |
| #4 | Japan | 5 | |
| #5 | Australia | 1 | |
| #6 | China | 1 | |
| #7 | New Zealand | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Basic materials chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Special acyclic compounds | |
| #4 | Preservation of human bodies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Asotra Satish | 15 |
| #2 | Yacobi Avraham | 13 |
| #3 | Gao Shen | 13 |
| #4 | Zadykowicz Jerzy | 5 |
| #5 | Gutman Daniella | 5 |
| #6 | Baidussi Wael | 5 |
| #7 | Moros Daniel A | 4 |
| #8 | Brodzsky Orit | 4 |
| #9 | Blumberg Tamar | 4 |
| #10 | Zissman Nataly | 4 |
| Publication | Filing date | Title |
|---|---|---|
| EP2029132A2 | Anti-histamine compositions and use thereof | |
| US2007185180A1 | Pharmaceutical formulation containing phenytoin sodium and magnesium stearate | |
| EP1888026A2 | A stable liquid formulation comprising desoximetasone and isopropyl myristate with reduced oxidized impurity during long-term storage |